WO2015092888A1 - P.o. medicine administration device - Google Patents

P.o. medicine administration device Download PDF

Info

Publication number
WO2015092888A1
WO2015092888A1 PCT/JP2013/083958 JP2013083958W WO2015092888A1 WO 2015092888 A1 WO2015092888 A1 WO 2015092888A1 JP 2013083958 W JP2013083958 W JP 2013083958W WO 2015092888 A1 WO2015092888 A1 WO 2015092888A1
Authority
WO
WIPO (PCT)
Prior art keywords
oral administration
viscous medium
drug
joint
administration device
Prior art date
Application number
PCT/JP2013/083958
Other languages
French (fr)
Japanese (ja)
Inventor
修司 盛本
大帆 三上
山内　浩
Original Assignee
株式会社モリモト医薬
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 株式会社モリモト医薬 filed Critical 株式会社モリモト医薬
Priority to PCT/JP2013/083958 priority Critical patent/WO2015092888A1/en
Priority to JP2015553279A priority patent/JP6168160B2/en
Priority to TW103138906A priority patent/TWI662959B/en
Publication of WO2015092888A1 publication Critical patent/WO2015092888A1/en

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/202—Separating means
    • A61J1/2024—Separating means having peelable seals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/06—Ampoules or carpules
    • A61J1/067—Flexible ampoules, the contents of which are expelled by squeezing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/202—Separating means
    • A61J1/2027—Separating means having frangible parts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2093—Containers having several compartments for products to be mixed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
    • A61J7/0015—Devices specially adapted for taking medicines
    • A61J7/0046—Cups, bottles or bags

Definitions

  • the present invention relates to a drug oral administration device for orally administering drugs, and particularly to a device for forming a drug-coated medium in which a plurality of coated drugs are integrated after coating individual drugs.
  • the container 11 of the viscous drug product 10 is a container in which the surface and the back of a pair of sheets made of, for example, polypropylene or polyethylene are bonded together, and a sealed space 12 is formed between the pair of sheets.
  • the structure of the container 11 is not restricted to said thing, What is necessary is just to have the space sealed in the inside.
  • the sealed space of the container 11 is divided into a liquid compartment 12a and a medicine compartment 12b by a separator 13.
  • a separator 13 For example, when the pressure in the liquid separating section 12a increases, the separating section 13 is formed so that the liquid compartment 12a and the medicine compartment 12b communicate with each other.
  • liquid 5 such as purified water such as purified water, tea, and juice is stored.
  • the above-described viscous drug preparation 1 of the present invention is accommodated in the medicine compartment 12b.
  • the aforementioned viscous product preparation 10 has the following points to be improved.
  • the liquid 5 contained in the liquid compartment 12a and the viscous drug substance preparation 1 contained in the medicine compartment 12b are separated when the container 11 is squeezed by hand. Mix together. That is, the isolation part 13 is formed so as to be in close contact with a force that can be gripped with a hand.
  • the present invention provides a drug coating in which a drug and a viscous medium are separately stored and portable, and each drug is coated and integrated with a plurality of drugs when orally administered. It is an object of the present invention to provide an oral drug administration device that can easily form a medium and can be administered orally.
  • a drug oral administration device is formed of a predetermined forming material having a planar shape, and has an open end portion having an opening and a closed closed end portion, which are positioned to face the open end portion.
  • a device for oral administration of medicines having a cylindrical shape, which is a viscous medium for coating medicines and medicines containing supplements for replenishing predetermined nutrients.
  • Viscous medium that forms a drug-coated medium integrated with the same, formed so as to connect the first side and the second side formed when the cylindrical planar shape is formed, and located opposite to each other A space formed by the intermediate joint, the intermediate joint, the side, and the closed end for joining the forming material, the viscous medium enclosure for enclosing the viscous medium, from the open end To descend toward the closed end,
  • the discharge port forming inclined joint portion that is formed so as to connect the first side portion from a predetermined end position between the first side portion and the second side portion, and joins the forming materials positioned opposite to each other.
  • the said edge part position has the discharge port formation inclination junction part formed in the said open end part side rather than the said intermediate junction part.
  • the viscous medium is cut to an appropriate size by moving the viscous medium along the discharge port forming inclined joint, and the cut viscous medium is formed between the second side portion and the end position. Can be discharged from the outlet. Therefore, a drug-coated medium in which drugs and a viscous medium are uniformly integrated can be easily formed.
  • the second side portion is an inclined side portion that rises from the open end portion toward the closed end portion, at a position facing the discharge port forming inclined joint portion.
  • An inclined side portion formed.
  • the viscous medium can move the viscous medium along the discharge port forming inclined joint portion and the inclined side portion, the viscous medium cut to an appropriate size can be formed more easily.
  • the discharge port forming inclined joint portion does not have a constant inclination angle.
  • the discharge port forming inclined joint is formed by a continuous curve.
  • the discharge port forming inclined joint portion has an arc shape.
  • a support joint that joins the forming material that is formed so as to connect the discharge port forming inclined joint and the first side portion, and facing each other, A support joint formed on the open end side of the intermediate joint.
  • the open end portion has a notch that exposes the other forming material in any one of the forming materials facing each other. To do.
  • the drugs can be easily put into the drug oral administration device.
  • the drug-coated medium when the drug-coated medium is orally administered, the drug-coated medium can be easily orally administered because the drug-coated medium can be disposed on the exposed molding material.
  • the oral drug administration device includes a storage state maintaining unit that maintains a storage state in which the open end is folded at least once toward the closed end.
  • the storage state maintaining part is a cut formed in the closed end part.
  • the storage state maintaining unit is formed continuously from the closed end on the side opposite to the viscous medium enclosing unit, and an end different from the closed end side is provided.
  • An opening is provided to store an end portion different from the closed end portion in the storage state.
  • the storage state maintaining part is formed on the first side part and / or the second side part, and is formed on the open end part side with respect to the intermediate joint part. And a notch formed on the closed end side with respect to the intermediate joint portion is engaged with each other.
  • the oral drug administration device has the predetermined drugs.
  • FIG. 1 is a front view of an oral drug administration device 100 that is an embodiment of an oral drug administration device according to the present invention. It is a rear view of the chemical
  • FIG. It is a figure which shows the usage method of the chemical
  • FIG. It is a figure which shows the usage method of the chemical
  • FIG. It is a figure which shows the usage method of the chemical
  • FIG. 1 shows a front view of the drug oral administration device 100
  • FIG. 2 shows a rear view of the drug oral administration device 100.
  • the oral drug administration device 100 is formed by using, as a forming material, a planar sheet formed of a material that is fused by heat, such as polypropylene or polyethylene.
  • the oral medicine administration device 100 includes a joint side portion 101, a bent side portion 102, a closed end portion 103, an open end portion 104, an intermediate joint portion 105, a discharge port forming joint portion 106, and a storage state maintenance. Part 107 is provided.
  • the oral drug administration device 100 forms a cylindrical shape by fusing the opposite ends of one sheet with heat to form the side joining region 101r.
  • the joining side portion 101 has one end portion 104T1 of the open end portion 104 and one end portion 103T1 of the corresponding closed end portion 103 at the boundary of the side joining region 101r on the side of the bent side portion 102 (described later). It is formed by tying.
  • the joining side portion 101 has an inclined side portion 101a.
  • the inclined side portion 101a is formed so as to increase in the direction from the open end portion 104 side toward the closed end portion 103 side.
  • the inclined side portion 101a is formed at a position facing the discharge port forming joint portion 106, particularly the second inclined joint portion 106b (described later).
  • the bonding side portion 101 that is a boundary on the side of the bent side portion 102 (described later) and the outer side portion 101e that is the boundary on the opposite side of the bonding side portion 101 are formed in parallel. Yes.
  • the folding side portion 102 is positioned to face the side portion where the joining side portion 101 is formed.
  • the folding side portion 102 has one end portion 104T2 of the open end portion 104 and a corresponding closed end at a boundary formed by pressing the sheet formed into a cylindrical shape by forming the joining side portion 101 into a planar shape. It is formed by connecting one end portion 103T2 of the portion 103.
  • the closed end portion 103 is formed by fusing one of the end portions of the sheet that has been formed into a cylindrical shape by the formation of the joining side portion 101 with heat.
  • the pharmaceutical oral administration device 100 forms a bag shape having three sides closed by the joint side portion 101, the folding side portion 102, and the closed end portion 103.
  • the open end 104 is positioned opposite the closed end 103.
  • the open end 104 has a first open end 104a and a second open end 104b.
  • the first open end 104a and the second open end 104b are positioned to face each other.
  • a semicircular cutout 104c is formed only in the second open end 104b.
  • the first open end 104a is exposed through the notch 104c, so that the medicine is introduced through the notch 104c and the viscous medium integrated with the medicine through the notch 104c is discharged / administered. Can be easily implemented.
  • the intermediate joint portion 105 is formed so as to cross the joint side portion 101 and the bent side portion 102.
  • the intermediate joint 105 includes a first intermediate joint 105a and a second intermediate joint 105b.
  • the first intermediate joint 105a and the second intermediate joint 105b are formed substantially in parallel, and the first intermediate joint 105a is formed on the closed end 103 side with respect to the second intermediate joint 105b. Is done.
  • the intermediate joint portion 105 is formed by placing a viscous medium in a medium sealing portion 203 (described later) and then fusing the sheet with heat.
  • the intermediate joint 105 is formed so that the viscous medium does not leak from the medium enclosure 203 when being carried or transported, and the viscous medium can be easily taken out from the medium enclosure 203 during use.
  • the intermediate joint portion 105 is formed so as to have a fusion strength such that the fusion is peeled off when the internal pressure of the viscous medium sealing portion 203 becomes higher than a predetermined level.
  • the discharge port forming joint portion 106 is located between the medium enclosing portion 203 and a drug placement portion 201 (described later), and cuts the viscous medium.
  • the discharge port forming joint portion 106 descends from the open end 104 side toward the closed end 103 side so as to connect a predetermined position between the joint side portion 101 and the fold side portion 102 and the fold side portion 102. It is formed as follows. An end 106t on the open end 104 side of the discharge port forming joint 106 is formed at a position away from the joint side 101 by a predetermined distance.
  • the discharge port forming joint 106 has a discharge port 106d for discharging the viscous medium.
  • the discharge port 106d is an opening through which the viscous medium passes when the viscous medium breaks the joint of the intermediate joint portion 105 and moves from the medium sealing portion 203 toward the medicine placement portion 201. Further, the discharge port forming joint portion 106 is formed between the joint side portion 101 and the end portion 106 t of the discharge port forming joint portion 106.
  • the discharge port 106 d is an opening having a distance smaller than the distance between the joining side portion 101 and the folding side portion 102 in the intermediate joining portion 105.
  • the discharge port forming joint 106 includes a first slope joint 106a, a second slope joint 106b, and a support joint 106c.
  • the viscous medium moves along a viscous medium movement line L106 formed by the first inclined joint 106a and the second inclined joint 106b.
  • the first inclined joint portion 106a and the second inclined joint portion 106b are formed obliquely from the open end portion 104 toward the closed end portion 103, respectively.
  • the first inclined joint portion 106a and the second inclined joint portion 106b have different inclination angles. That is, the discharge port forming joint portion 106 does not have a constant inclination angle.
  • the first inclined joint portion 106a has a gentler inclination angle than the second inclined joint portion 106b.
  • the 1st inclination junction part 106a is formed in the open end part 104 side rather than the 2nd inclination junction part 106b.
  • the viscous medium having a predetermined size is stably discharged from the discharge port 106d. be able to.
  • the support joint portion 106c is formed so as to connect from the vicinity of the joint point between the first slope joint portion 106a and the second slope joint portion 106b to the folding side portion 102.
  • the discharge port forming joint portion 106 is formed so that the end portion 106t of the discharge port forming joint portion 106 is located closer to the open end portion 014 than the second intermediate joint portion 105b.
  • the storage state maintaining unit 107 is formed in the closed end portion 103.
  • the storage state maintaining portion 107 is formed as a cut larger than the width of the open end portion 104. Thereby, an end portion different from the closed end portion 103 in the storage state (described later) in which the open end portion 104 is bent can be easily inserted into the storage state maintaining portion 107.
  • the space formed by the bonding side portion 101, the folding side portion 102, and the second intermediate bonding portion 105b functions as a medicine placement portion 201.
  • a predetermined medicine T is placed in the medicine placement unit 201.
  • the drug T to be arranged may have any shape such as a tablet, a capsule, or a granule.
  • the tablet is illustrated as the chemical
  • the space formed by the joining side portion 101, the folding side portion 102, the closed end portion 103, and the first intermediate joining portion 105a functions as the viscous medium enclosing portion 203.
  • a viscous medium having a predetermined viscosity and covering each individual drug and forming a drug-coated medium integrated with the coated drug is encapsulated.
  • so-called jelly is used as the viscous medium.
  • the space formed between the first inclined joint portion 106a, the support joint portion 106c, and the bent side portion 102 functions as the drug receiving portion 205.
  • the drug receiving unit 205 stably holds the drug when the drug oral administration device 100 is used. Thereby, the user of the drug oral administration device 100 can easily mix the viscous medium and the drug.
  • Second Usage Method When the drug oral administration device 100 is used, there are a preparation stage in which a drug such as a tablet T is sealed in the drug placement unit 201 and an oral administration stage in which the drug-coated medium is orally administered. Hereinafter, each stage will be described.
  • the oral medicine administration device 100 is provided to a user (hereinafter referred to as encapsulator) who encapsulates the medicine in a state where a predetermined viscous medium is encapsulated in the viscous medium enclosure 203 in advance.
  • encapsulator a user who encapsulates the medicine in a state where a predetermined viscous medium is encapsulated in the viscous medium enclosure 203 in advance.
  • the preparation stage of the oral drug administration device 100 will be described with reference to FIGS.
  • the encapsulator who intends to enclose the drug T in the drug oral administration device 100 arranges the drug T in the open end 104, moves it in the direction of the arrow a ⁇ b> 31, and inputs it into the drug arrangement unit 201 To do.
  • the open end 104 is opened in a diamond shape.
  • the first open end 104a where the notch 104c is not formed is positioned on the lower side
  • the second open end 104b where the notch 104c is formed is positioned on the upper side, via the notch 104c.
  • the tablet T is arrange
  • the open end 104 Since the open end 104 is opened in a diamond shape, the first open end 104a has a convex shape on the lower side. Therefore, the tablet T can be easily received, and when the tablet T is inserted, it is spilled sideways. Can prevent failure.
  • the encapsulator bends the medicine end portion 104 in the direction of the medicine placement portion 201, that is, the direction of the arrow a ⁇ b> 41, with the open end portion 104 facing inward.
  • the pharmaceutical oral administration device 100 can be in a two-fold state in which the open end 104 is folded.
  • the open end portion 104 is folded, it is folded at a position where at least the notch portion 104c is completely inside.
  • the encapsulator further moves the drug placement part 201 in a state where the open end part 104 is folded along the first intermediate joint part 105a as shown in FIG.
  • the encapsulator After folding in the direction of the viscous medium enclosing portion 203, that is, in the direction of the arrow a51, an end different from the end on the second intermediate joint portion 105b side of the drug placement portion 201, that is, an end where the open end is folded is indicated by an arrow a53.
  • It inserts in the accommodation state maintenance part 107 along a direction.
  • medical agent oral administration apparatus 100 can be made into a three-fold state.
  • medicine oral administration device 100 into a folded state, while being compactly packable the form at the time of carrying can be stabilized.
  • the oral administration person who orally administers the medicine stored in the medicine oral administration device 100 or makes it oral by the other person shows the medicine oral administration device 100 in a trifolded state as shown in FIG. As shown in FIG.
  • the oral administration person presses the viscous medium enclosing portion 203 with a finger.
  • the pressure inside the viscous medium enclosure 203 increases.
  • the internal pressure of the viscous medium enclosing part 203 becomes higher than a predetermined level, the fusion bonding of the intermediate joint part 105 is peeled off, and the viscous medium located inside the medium enclosing part 203 moves in the direction of the medicine placement part 201.
  • the viscous medium is discharged from the arrow a61 direction to the arrow a65 direction along the second inclined joint portion 106b and the first inclined joint portion 106a of the discharge port forming joint portion 106. That is, the viscous medium moves along the viscous medium movement line L106.
  • the viscous medium moves from the intermediate joint portion 105 toward the discharge port 106d, which is an opening having a distance smaller than the distance between the joint side portion 101 and the folding side portion 102 in the intermediate joint portion 105. .
  • the viscous medium is a compression force applied to the viscous medium enclosure 203, that is, the pressure applied to the viscous medium when the viscous medium is directed from the wide medium enclosure 201 to the narrow discharge port 106d, or the viscous medium itself.
  • the material is cut into an appropriate size.
  • the viscous medium is also discharged in the direction of the arrow a63 along the inclined side portion 101a of the joining side portion 101. For this reason, since a viscous medium merges in the vicinity of the intersection of the arrow a61 direction and the arrow a63 direction, cutting is further promoted.
  • the cut viscous medium is discharged from the discharge port 106d to the medicine placement unit 201 along the arrow a67.
  • the cut viscous medium is discharged to the medicine receiving unit 205 side. Since the medicine T is located in the medicine receiving part 205, the cut viscous medium and the medicine T can be easily integrated. Thereby, the medicine covering medium in which the medicine T and the viscous medium located inside the medicine placement unit 201 are integrated can be generated.
  • a drug-coated medium in which the drug is uniformly included in the viscous medium can be generated.
  • the drug-coated medium is moved in the direction of the open end 104, that is, in the direction of the arrow a71, and the drug-coated medium is disposed on the first open end 104a. Then, the drug-coated medium is orally administered from the first open end 104a.
  • Example 1 in Example 1 described above, so-called jelly was used as the viscous medium.
  • the viscous medium has a predetermined viscosity and a predetermined strength, is coated with a drug, and a plurality of coated drugs are integrated.
  • the present invention is not limited to the examples as long as the formed drug-coated medium is formed.
  • tablet T is shown as the drug, but the drug is not limited to the illustrated one as long as it is a drug.
  • the drug may be a mini tablet, pellet, hard capsule, soft capsule, inclusion, granule, powder, API.
  • a supplement for supplementing a predetermined nutrient may be used instead of the drug.
  • Example 1 drug oral administration device 100 Although polypropylene or the like is shown as the material of the sheet forming the above-described Example 1 drug oral administration device 100, the joint side portion 101, the intermediate joint portion 105, and the discharge port forming joint portion 106 can be formed. If there is, it is not limited to the example. For example, you may make it form with soft materials, such as aluminum. Further, it may be transparent or translucent.
  • the storage state maintenance unit 107 is configured by the cut formed in the closed end portion 103.
  • the storage state in which the oral medicine administration device is folded can be maintained. If it is, it is not limited to the thing of illustration.
  • the storage state maintaining unit 307 may be formed in a direction that is continuous with the joint end 103 and in a direction different from the viscous medium enclosing unit 203. .
  • the storage state maintaining unit 307 has an end storage opening that is positioned opposite to the joint end 103. As shown in FIG. 9, with the open end portion 104 folded, the drug placement portion 203 is folded so as to overlap the viscous medium enclosing portion 203. The storage state maintaining unit 307 is also folded so as to overlap the viscous medium enclosing unit 203. Then, one end of the folded drug placement unit 203 is inserted into the end storage opening of the storage state maintaining unit 307, and the storage state of the drug oral administration device 300 during carrying is maintained.
  • the storage state may be maintained by the storage state maintaining unit 407 formed in the side joint region 101r.
  • the storage state maintaining unit 407 is formed in the first cutout 407a, the second cutout 407b formed in the bonding side portion 101 corresponding to the medicine placement portion 203, and the bonding side portion 101 corresponding to the viscous medium enclosing portion 203.
  • the third cutout 407c and the fourth cutout 407d are provided.
  • the first cutout 407 a and the second cutout 407 b are formed as cuts that become narrower from the end of the joining side portion 101 toward the drug placement portion 203.
  • the third cutout 407 c and the fourth cutout 407 d are formed as cuts that widen from the end of the joining side portion 101 toward the viscous medium sealing portion 203.
  • the first notch 407a When forming the storage state during carrying, as shown in FIG. 11A, the first notch 407a, as shown in FIG. 11B in which the X region shown in FIG. A part of the tip of the second notch 407b is inserted into the third notch 407c and the fourth notch 407d, and the first notch 407a and the second notch 407b are inserted into the third notch 407c and the fourth notch. 407d is engaged. Thereby, the medicine oral administration device 400 can be maintained in the housed state.
  • the hatched portions of the first cutout 407a and the second cutout 407b show the portions engaged with the third cutout 407c and the fourth cutout 407d.
  • the discharge port forming joint portion 106 includes the first inclined joint portion 106a and the second inclined joint portion 106b having different inclination angles.
  • the present invention is not limited to the example as long as the inclination angle is not constant.
  • the viscous medium moving line L506 is formed by the arc-shaped discharge port forming joint 506.
  • the divided inclined joint obtained by dividing the first inclined joint portion 106a and the second inclined joint portion 106b of the oral medicine administration device 100 in Example 1 described above into a plurality of parts.
  • the portions 206a to 206d may be formed.
  • the distance between the divided joints may be a distance that allows the viscous medium to move along the respective divided joints without leaking from the gap.
  • the viscous medium movement line L606 is formed by the divided inclined joints 206a to 206d and the space therebetween.
  • Support joint 106c In the drug oral administration device 100 in the first embodiment described above, the discharge port forming joint 106 has the support joint 106c, but like the drug oral administration device 600 shown in FIG. In addition, the support joint 106c may not be formed. Also, the space between the support joint 106c and the second inclined joint 106b shown in FIG. 1 is fused, and the first inclined joint 106a, the second inclined joint 106b, and the support joint 106c are connected. , And may be integrally fused.
  • Side joint region 101r In the oral drug administration device 100 in Example 1 described above, the joint side portion 101 and the external side portion 101e in the side joint region 101r are formed in parallel.
  • the shape is not limited to the illustrated example as long as the joining side portion 101 having a shape can be formed.
  • the outer side portion 651 e may be formed with a side joining region 651 r having a horizontal shape different from that of the joining side portion 101.
  • the joint side portion 101 has the inclined side portion 101a.
  • the joining side portion 701 includes one end portion 104T1 of the open end portion 104 and one end portion 703T1 of the corresponding closed end portion 703 at the boundary of the side joining region 701r on the folded side portion 102 side. Connected to form a straight line.
  • the folded side portion 102 corresponds to one end portion 104T2 of the open end portion 104 at a boundary formed by press-contacting a sheet having a cylindrical shape by forming the joining side portion 101 into a planar shape. It is formed on a straight line connecting one end portion 703T2 of the closed end portion 703.
  • Cylindrical shape of the drug oral administration device 100 In the drug oral administration device 100 in Example 1 described above, the end of one sheet is fused and, as shown in FIG. Although the oral medicine administration device 100 has a cylindrical shape by forming the joint side portion 101, it is not limited to the illustrated one as long as it can have a cylindrical shape. For example, both ends of two sheets are fused, and a joining side portion 101 is formed on one side as in the oral medicine administration device 800 shown in FIG. 802 may be formed.
  • Intermediate joint 105 In the first embodiment, the intermediate joint 105 has the first intermediate joint 105a and the second intermediate joint 105b, but only one of them is formed. May be. Three or more intermediate joints may be formed.
  • Discharge port forming portion In the above-described first embodiment, the discharge port inclined joint portion 106 forms the viscous medium cutting portion that cuts the viscous medium, but the discharge port inclined joint portion 106 is not formed. Alternatively, a viscous medium cutting part may be formed.
  • the discharge port forming unit 806 located between the medium enclosing unit 203 and the drug placement unit 201 is formed.
  • the discharge port forming part 806 is formed by fusing the forming materials positioned opposite to each other in an island shape.
  • the discharge port forming portion 806 is configured by discharge port forming inclined joint portions 806a and 806b.
  • the viscous medium breaks the joint of the intermediate joint portion 105 and moves from the medium sealing portion 203 toward the drug placement portion 201, the viscous medium is discharged from the discharge ports 806d1 to 806d1 ⁇ formed by the discharge port forming inclined joint portions 806a and 806b. Pass 806d3.
  • the discharge ports 806d1 to 806d3 are each formed by an opening having a distance smaller than the distance between the bonding side portion 101 and the folding side portion 102 in the intermediate bonding portion 105.
  • the oral drug administration device 100 has one discharge port 106d, but may have a plurality of discharge ports.
  • the discharge port has an island-shaped joint 906a, and has two discharge ports 906d1 and 906d2 in total, one above and below the island-shaped joint 906a.
  • the forming unit 906 may be formed.
  • the oral drug administration device 100 has a cylindrical shape in which three sides are closed by the joint side portion 101, the bent portion 102, and the closed end portion 103.
  • the present invention is not limited to the illustrated example as long as the bag shape is closed on three sides.
  • the outer shape of the oral drug administration device 1000 may be a fish shape.
  • the present invention stores a drug and a viscous medium in a separated state so that they can be carried, and when orally administered, a drug-coated medium formed by the viscous medium and the drug is formed and orally administered. Can be used as a device.
  • Oral administration device 307 Storage state maintaining unit 400 ⁇ Oral medicine administration device 407... Storage state maintaining unit 407a... First cutout 407b... Second cutout 407c... Third cutout 407d.
  • Oral medicine administration device 506 Drain formation joint portion 600 ⁇ Oral medicine administration device 700 ⁇ Oral medicine administration device 701 ⁇ Joint side portion 800 ⁇ ⁇ Oral drug administration device 802 ⁇ Joint side portion 900 ⁇ Oral drug administration device 1000 ⁇ Oral drug administration device

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Fluid Mechanics (AREA)
  • Hematology (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicinal Preparation (AREA)

Abstract

[Problem] To provide a p.o. medicine administration device with which: medicine and a viscous medium are made portable by being held separately; and when taking the medicine orally, after covering the individual medicines, a drug-covering medium in which the covered medicines are combined with the viscous medium can be easily formed and given orally. [Solution] The p.o. medicine administration device (100) comprises an outlet-forming junction (106). The outlet-forming junction (106) comprises a first inclined junction section (106a) and a second inclined junction section (106b). The first inclined junction section (106a) and the second inclined junction section (106b) have mutually differing angles of inclination. The first inclined junction section (106a) has a more gradual angle of inclination than the second inclined junction section (106b). The first inclined junction section (106a) also is formed on the open end (104)-side of the second inclined junction section (106b). By forming the first inclined junction section (106a) and the second inclined junction section (106b) of differing angles of inclination to be contiguous, it is possible to stably discharge a viscous medium of a specified size from the outlet.

Description

薬剤類経口投与装置Drug oral administration device
　本発明は、薬剤類を経口投与するための薬剤類経口投与装置に関し、特に、個々の薬剤類を被覆した上で、複数の被覆した薬剤類を一体化した薬剤被覆媒体を形成するものに関する。 BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a drug oral administration device for orally administering drugs, and particularly to a device for forming a drug-coated medium in which a plurality of coated drugs are integrated after coating individual drugs.
　従来の粘体状薬品調製製品１０について図２１を用いて説明する。粘体状薬品調製製品１０の容器１１は、素材が例えばポリプロピレンやポリエチレン等である一対のシートの表面と背面が貼り合わされ、一対のシートの間に密閉した空間１２が形成されたものである。なお、容器１１の構成は上記のものに限られず、その内部に密閉した空間を有するものであればよい。 A conventional viscous drug product 10 will be described with reference to FIG. The container 11 of the viscous drug product 10 is a container in which the surface and the back of a pair of sheets made of, for example, polypropylene or polyethylene are bonded together, and a sealed space 12 is formed between the pair of sheets. In addition, the structure of the container 11 is not restricted to said thing, What is necessary is just to have the space sealed in the inside.
　前記容器１１の密閉した空間には、隔離部１３によって液体用隔室１２ａ　と薬剤用隔室１２ｂとに分割されている。この隔離部１３は、例えば液体用隔離部１２ａ内の圧力が高くなると、液体用隔室１２ａと薬剤用隔室１２ｂとの間が連通するように形成されている。 The sealed space of the container 11 is divided into a liquid compartment 12a and a medicine compartment 12b by a separator 13. For example, when the pressure in the liquid separating section 12a increases, the separating section 13 is formed so that the liquid compartment 12a and the medicine compartment 12b communicate with each other.
　前記液体用隔室１２ａ　には、例えば精製水やお茶、ジュース等の清涼飲料水などの液体５が収容されている。一方、薬剤用隔室１２ｂ　には、上述した本発明の粘体状薬品調製剤１が収容されている。 In the liquid compartment 12a, for example, liquid 5 such as purified water such as purified water, tea, and juice is stored. On the other hand, the above-described viscous drug preparation 1 of the present invention is accommodated in the medicine compartment 12b.
　粘体状薬品調製製品１０の容器１１を手で強く握ると、液体用隔室１２ａや薬剤用隔室１２ｂが圧迫され、その内部の圧力が高くなる。すると、容器１１の隔離部１３が液体用隔室１２ａと薬剤用隔室１２ｂとを分割しておくことができなくなり、液体用隔室１２ａ　と薬剤用隔室１２ｂ　とが連通される。このため、液体用隔室１２ａ内の液体５と薬剤用隔室１２ｂ内の粘体状薬品調製剤１とが混じり合うので、粘体状薬品調製剤１が粘体状に調製される。（特許文献１） If the container 11 of the viscous drug product preparation product 10 is squeezed by hand, the liquid compartment 12a and the medicine compartment 12b are compressed, and the internal pressure increases. Then, the isolation part 13 of the container 11 cannot separate the liquid compartment 12a and the medicine compartment 12b, and the liquid compartment 12a and the medicine compartment 12b are communicated with each other. For this reason, since the liquid 5 in the liquid compartment 12a and the viscous chemical preparation 1 in the pharmaceutical compartment 12b are mixed, the viscous chemical preparation 1 is prepared in a viscous form. (Patent Document 1)
特開２００３－１３７８１７号公報JP 2003-137817 A
　前述の粘体状薬品調製製品１０には、以下に示すような改善すべき点がある。液体用隔室１２ａ　に収容されている液体５と、薬剤用隔室１２ｂ　に収容されている粘体状薬品調製剤１とは、容器１１を手で強く握ると、隔離部１３が破壊されて、混じり合う。すなわち、隔離部１３は、手で強く握る程度の力で密着するように形成されている。 The aforementioned viscous product preparation 10 has the following points to be improved. The liquid 5 contained in the liquid compartment 12a and the viscous drug substance preparation 1 contained in the medicine compartment 12b are separated when the container 11 is squeezed by hand. Mix together. That is, the isolation part 13 is formed so as to be in close contact with a force that can be gripped with a hand.
　一方、薬剤をゼリー等の粘性媒体と一緒に飲み込むことによって、薬剤の経口投与を補助する場合、薬剤と粘性媒体とを隣接して配置し、前述の隔離部１３を配置したとしても、両者を混合するには手で強く握るほどの相当の力を要する。また、粘性媒体に強く握るほどの力を加えると、粘性媒体が勢いよく飛び散ってしまうという不具合が生ずる可能性がある。 On the other hand, in the case of assisting oral administration of the drug by swallowing the drug together with a viscous medium such as jelly, even if the drug and the viscous medium are arranged adjacent to each other, Mixing requires a considerable amount of force to hold it with your hand. In addition, when a force is applied to the viscous medium so as to be strongly gripped, there is a possibility that the viscous medium scatters vigorously.
　そこで、本発明は、薬剤と粘性媒体とを分離した状態で収納して、携行可能とし、経口投与する際に、個々の薬剤を被覆した上で、複数の被覆した薬剤を一体化した薬剤被覆媒体を容易に形成して、経口投与できる薬剤経口投与装置を提供することを目的とする。 Accordingly, the present invention provides a drug coating in which a drug and a viscous medium are separately stored and portable, and each drug is coated and integrated with a plurality of drugs when orally administered. It is an object of the present invention to provide an oral drug administration device that can easily form a medium and can be administered orally.
　本発明に係る薬剤累経口投与装置は、平面形状の所定の形成材によって形成され、開口を有する開端部、及び、閉じられた閉端部であって、前記開端部に対向して位置するものを有し、筒状形状を有する薬剤類経口投与装置であって、薬剤、及び、所定の栄養素を補給するためのサプリメントを含む薬剤類を被覆するための粘性媒体であって、被覆した前記薬剤類と一体化した薬剤被覆媒体を形成する粘性媒体、前記筒状形状の平面形状とした際に形成される第１側部と第２側部とを結ぶように形成され、対向して位置する前記形成材を接合する中間接合部、前記中間接合部、前記側部、及び、前記閉端部によって形成される空間であって、前記粘性媒体を封入する粘性媒体封入部、前記開端部から前記閉端部に向かって下降するように、前記第１側部と前記第２側部との間の所定の端部位置から前記第１側部を結ぶように形成され、対向して位置する前記形成材を接合する排出口形成傾斜接合部であって、前記端部位置が前記中間接合部よりも前記開端部側に形成される排出口形成傾斜接合部、を有する。 A drug oral administration device according to the present invention is formed of a predetermined forming material having a planar shape, and has an open end portion having an opening and a closed closed end portion, which are positioned to face the open end portion. A device for oral administration of medicines having a cylindrical shape, which is a viscous medium for coating medicines and medicines containing supplements for replenishing predetermined nutrients. Viscous medium that forms a drug-coated medium integrated with the same, formed so as to connect the first side and the second side formed when the cylindrical planar shape is formed, and located opposite to each other A space formed by the intermediate joint, the intermediate joint, the side, and the closed end for joining the forming material, the viscous medium enclosure for enclosing the viscous medium, from the open end To descend toward the closed end, The discharge port forming inclined joint portion that is formed so as to connect the first side portion from a predetermined end position between the first side portion and the second side portion, and joins the forming materials positioned opposite to each other. And the said edge part position has the discharge port formation inclination junction part formed in the said open end part side rather than the said intermediate junction part.
　これにより、粘性媒体を排出口形成傾斜接合部に沿って移動させることによって、粘性媒体を適度な大きさに裁断し、裁断した粘性媒体を、第２側部と端部位置との間に形成される排出口から排出することができる。よって、薬剤類と粘性媒体とを均一に一体化した薬剤被覆媒体を容易に形成できる。 Accordingly, the viscous medium is cut to an appropriate size by moving the viscous medium along the discharge port forming inclined joint, and the cut viscous medium is formed between the second side portion and the end position. Can be discharged from the outlet. Therefore, a drug-coated medium in which drugs and a viscous medium are uniformly integrated can be easily formed.
　本発明に係る薬剤類経口投与装置では、前記第２側部は、前記開端部から前記閉端部に向かって上昇する傾斜側部であって、前記排出口形成傾斜接合部に対向する位置に形成される傾斜側部、を有する。 In the pharmaceutical oral administration device according to the present invention, the second side portion is an inclined side portion that rises from the open end portion toward the closed end portion, at a position facing the discharge port forming inclined joint portion. An inclined side portion formed.
　これにより、粘性媒体が粘性媒体を排出口形成傾斜接合部及び傾斜側部に沿って移動させることができるため、より容易に適度な大きさに裁断された粘性媒体を形成できる。 Thereby, since the viscous medium can move the viscous medium along the discharge port forming inclined joint portion and the inclined side portion, the viscous medium cut to an appropriate size can be formed more easily.
　本発明に係る薬剤類経口投与装置では、前記排出口形成傾斜接合部は、一定した傾斜角度を有さないこと、を特徴とする。 In the pharmaceutical oral administration device according to the present invention, the discharge port forming inclined joint portion does not have a constant inclination angle.
　これにより、容易に適度な大きさに裁断された粘性媒体を形成できる。 This makes it possible to form a viscous medium that is easily cut into an appropriate size.
　本発明に係る薬剤類経口投与装置では、前記排出口形成傾斜接合部は、連続した曲線によって形成されていること、を特徴とする。 In the pharmaceutical oral administration device according to the present invention, the discharge port forming inclined joint is formed by a continuous curve.
　これにより、容易に適度な大きさに裁断された粘性媒体を形成できる。 This makes it possible to form a viscous medium that is easily cut into an appropriate size.
　本発明に係る薬剤類経口投与装置では、前記排出口形成傾斜接合部は、円弧形状を有すること、を特徴とする。 In the pharmaceutical oral administration device according to the present invention, the discharge port forming inclined joint portion has an arc shape.
　これにより、容易に適度な大きさに裁断された粘性媒体を形成できる。 This makes it possible to form a viscous medium that is easily cut into an appropriate size.
　本発明に係る薬剤経口投与装置では、前記排出口形成傾斜接合部と前記第１側部とを接続するように形成され、対向して位置する前記形成材を接合する支持接合部であって、前記中間接合部よりも前記開端部側に形成される支持接合部、を有する。 In the oral drug administration device according to the present invention, a support joint that joins the forming material that is formed so as to connect the discharge port forming inclined joint and the first side portion, and facing each other, A support joint formed on the open end side of the intermediate joint.
　これにより、支持接合部及び排出口形成傾斜接合部によって形成される空間に、薬剤類を受容できる。よって、薬剤被覆媒体を形成する際に、容易に、薬剤類と裁断された粘性媒体とを一体化できる。 Thereby, drugs can be received in the space formed by the support joint and the discharge port forming inclined joint. Therefore, when forming the medicine coating medium, the medicines and the cut viscous medium can be easily integrated.
　本発明に係る薬剤類経口投与装置では、前記開端部は、対向して位置する前記形成材のいずれか一方の前記形成材に、他方の前記形成材を露出する切り欠き有すること、を特徴とする。 In the pharmaceutical oral administration device according to the present invention, the open end portion has a notch that exposes the other forming material in any one of the forming materials facing each other. To do.
　これにより、薬剤類を容易に薬剤類経口投与装置内に投入できる。また、薬剤被覆媒体の経口投与する際に、薬剤被覆媒体を露出した成形材上に配置できるため、容易に薬剤被覆媒体を経口投与できる。 Thereby, the drugs can be easily put into the drug oral administration device. In addition, when the drug-coated medium is orally administered, the drug-coated medium can be easily orally administered because the drug-coated medium can be disposed on the exposed molding material.
　本発明に係る薬剤経口投与装置では、前記開端部を少なくとも１回、前記閉端部側に折りたたんだ収納状態を維持する収納状態維持部、を有する。 The oral drug administration device according to the present invention includes a storage state maintaining unit that maintains a storage state in which the open end is folded at least once toward the closed end.
　これにより、容易に収納状態を維持できる。 This makes it easy to maintain the storage state.
　本発明に係る薬剤経口投与装置では、前記収納状態維持部は、前記閉端部に形成される切れ込みであること、を特徴とする。 In the oral medicine administration device according to the present invention, the storage state maintaining part is a cut formed in the closed end part.
　これにより、容易に収納状態を維持できる。 This makes it easy to maintain the storage state.
　本発明に係る薬剤経口投与装置では、前記収納状態維持部は、前記粘性媒体封入部とは反対側に前記閉端部から連続して形成され、前記閉端部側とは異なる端部が、前記収納状態における前記閉端部とは異なる端部を収納するために開口していること、を特徴とする。 In the oral drug administration device according to the present invention, the storage state maintaining unit is formed continuously from the closed end on the side opposite to the viscous medium enclosing unit, and an end different from the closed end side is provided. An opening is provided to store an end portion different from the closed end portion in the storage state.
　これにより、容易に収納状態を維持できる。 This makes it easy to maintain the storage state.
　本発明に係る薬剤経口投与装置では、前記収納状態維持部は、前記第１側部及び／又は前記第２側部に形成され、前記中間接合部に対して前記開端部側に形成される切れ込みと、前記中間接合部に対して前記閉端部側に形成される切れ込みとを、互いに係合させるものであること、を特徴とする。 In the oral medicine administration device according to the present invention, the storage state maintaining part is formed on the first side part and / or the second side part, and is formed on the open end part side with respect to the intermediate joint part. And a notch formed on the closed end side with respect to the intermediate joint portion is engaged with each other.
　これにより、容易に収納状態を維持できる。 This makes it easy to maintain the storage state.
　本発明に係る薬剤経口投与装置では、所定の前記薬剤類、を有する。 The oral drug administration device according to the present invention has the predetermined drugs.
　これにより、薬剤類を有する薬剤類経口投与装置を容易に提供できる。
Thereby, the chemical | medical agent oral administration apparatus which has chemical | medical agents can be provided easily.
本発明に係る薬剤類経口投与装置の一実施例である薬剤経口投与装置１００の正面図である。1 is a front view of an oral drug administration device 100 that is an embodiment of an oral drug administration device according to the present invention. 図１に示す薬剤経口投与装置１００の背面図である。It is a rear view of the chemical | medical agent oral administration apparatus 100 shown in FIG. 薬剤経口投与装置１００の使用方法を示す図である。It is a figure which shows the usage method of the chemical | medical agent oral administration apparatus 100. FIG. 薬剤経口投与装置１００の使用方法を示す図である。It is a figure which shows the usage method of the chemical | medical agent oral administration apparatus 100. FIG. 薬剤経口投与装置１００の使用方法を示す図である。It is a figure which shows the usage method of the chemical | medical agent oral administration apparatus 100. FIG. 薬剤経口投与装置１００の使用方法を示す図である。It is a figure which shows the usage method of the chemical | medical agent oral administration apparatus 100. FIG. 薬剤経口投与装置１００の使用方法を示す図である。It is a figure which shows the usage method of the chemical | medical agent oral administration apparatus 100. FIG. 本発明に係る薬剤類経口投与装置のその他の実施例を示す図である。It is a figure which shows the other Example of the chemical | medical agent oral administration apparatus which concerns on this invention. 本発明に係る薬剤類経口投与装置のその他の実施例を示す図である。It is a figure which shows the other Example of the chemical | medical agent oral administration apparatus which concerns on this invention. 本発明に係る薬剤類経口投与装置のその他の実施例を示す図である。It is a figure which shows the other Example of the chemical | medical agent oral administration apparatus which concerns on this invention. 本発明に係る薬剤類経口投与装置のその他の実施例を示す図である。It is a figure which shows the other Example of the chemical | medical agent oral administration apparatus which concerns on this invention. 本発明に係る薬剤類経口投与装置のその他の実施例を示す図である。It is a figure which shows the other Example of the chemical | medical agent oral administration apparatus which concerns on this invention. 本発明に係る薬剤類経口投与装置のその他の実施例を示す図である。It is a figure which shows the other Example of the chemical | medical agent oral administration apparatus which concerns on this invention. 本発明に係る薬剤類経口投与装置のその他の実施例を示す図である。It is a figure which shows the other Example of the chemical | medical agent oral administration apparatus which concerns on this invention. 本発明に係る薬剤類経口投与装置のその他の実施例を示す図である。It is a figure which shows the other Example of the chemical | medical agent oral administration apparatus which concerns on this invention. 本発明に係る薬剤類経口投与装置のその他の実施例を示す図である。It is a figure which shows the other Example of the chemical | medical agent oral administration apparatus which concerns on this invention. 本発明に係る薬剤類経口投与装置のその他の実施例を示す図である。It is a figure which shows the other Example of the chemical | medical agent oral administration apparatus which concerns on this invention. 本発明に係る薬剤類経口投与装置のその他の実施例を示す図である。It is a figure which shows the other Example of the chemical | medical agent oral administration apparatus which concerns on this invention. 本発明に係る薬剤類経口投与装置のその他の実施例を示す図である。It is a figure which shows the other Example of the chemical | medical agent oral administration apparatus which concerns on this invention. 本発明に係る薬剤類経口投与装置のその他の実施例を示す図である。It is a figure which shows the other Example of the chemical | medical agent oral administration apparatus which concerns on this invention. 薬剤経口投与装置の従来技術を示す図である。It is a figure which shows the prior art of a chemical | medical agent oral administration apparatus.
　以下、本発明の実施例について、図面を参照しながら詳細に説明していく。 Hereinafter, embodiments of the present invention will be described in detail with reference to the drawings.
第１　構成
　本発明に係る薬剤経口投与装置の一実施例である薬剤経口投与装置１００について、図１及び図２を用いて説明する。図１は、薬剤経口投与装置１００の正面図を、図２は、薬剤経口投与装置１００の背面図を、それぞれ示している。 First Configuration A drug oral administration device 100, which is an example of a drug oral administration device according to the present invention, will be described with reference to FIGS. FIG. 1 shows a front view of the drug oral administration device 100, and FIG. 2 shows a rear view of the drug oral administration device 100.
　薬剤経口投与装置１００は、例えば、ポリプロピレンやポリエチレン等、熱によって融着する素材によって形成された平面形状のシートを形成材として用いて形成される。 The oral drug administration device 100 is formed by using, as a forming material, a planar sheet formed of a material that is fused by heat, such as polypropylene or polyethylene.
　図１に示すように、薬剤経口投与装置１００は、接合側部１０１、折れ側部１０２、閉端部１０３、開端部１０４、中間接合部１０５、排出口形成接合部１０６、及び、収納状態維持部１０７を有している。 As shown in FIG. 1, the oral medicine administration device 100 includes a joint side portion 101, a bent side portion 102, a closed end portion 103, an open end portion 104, an intermediate joint portion 105, a discharge port forming joint portion 106, and a storage state maintenance. Part 107 is provided.
　薬剤経口投与装置１００は、一枚のシートの対向して位置する端部同士を熱によって融着し、側部接合領域１０１ｒを形成することによって、筒状形状を形成する。接合側部１０１は、側部接合領域１０１ｒの折れ側部１０２（後述）の側の境界に、開端部１０４の一つの端部１０４Ｔ１と、対応する閉端部１０３の一つの端部１０３Ｔ１とを結んで形成される。接合側部１０１は、傾斜側部１０１ａを有している。傾斜側部１０１ａは、開端部１０４側から閉端部１０３側に向かう方向に増加するように形成される。傾斜側部１０１ａは、排出口形成接合部１０６、特に、第２傾斜接合部１０６ｂ（後述）に対向する位置に形成される。なお、側部接合領域１０１ｒにおいて、折れ側部１０２（後述）の側の境界である接合側部１０１と、接合側部１０１とは反対側の境界である外側部１０１ｅとは平行に形成されている。 The oral drug administration device 100 forms a cylindrical shape by fusing the opposite ends of one sheet with heat to form the side joining region 101r. The joining side portion 101 has one end portion 104T1 of the open end portion 104 and one end portion 103T1 of the corresponding closed end portion 103 at the boundary of the side joining region 101r on the side of the bent side portion 102 (described later). It is formed by tying. The joining side portion 101 has an inclined side portion 101a. The inclined side portion 101a is formed so as to increase in the direction from the open end portion 104 side toward the closed end portion 103 side. The inclined side portion 101a is formed at a position facing the discharge port forming joint portion 106, particularly the second inclined joint portion 106b (described later). In the side bonding region 101r, the bonding side portion 101 that is a boundary on the side of the bent side portion 102 (described later) and the outer side portion 101e that is the boundary on the opposite side of the bonding side portion 101 are formed in parallel. Yes.
　折れ側部１０２は、接合側部１０１が形成されている側部に対向して位置する。折れ側部１０２は、接合側部１０１を形成することによって筒状形状としたシートを平面形状に圧接することによって形成される境界に、開端部１０４の一つの端部１０４Ｔ２と、対応する閉端部１０３の一つの端部１０３Ｔ２とを結んで形成される。 The folding side portion 102 is positioned to face the side portion where the joining side portion 101 is formed. The folding side portion 102 has one end portion 104T2 of the open end portion 104 and a corresponding closed end at a boundary formed by pressing the sheet formed into a cylindrical shape by forming the joining side portion 101 into a planar shape. It is formed by connecting one end portion 103T2 of the portion 103.
　閉端部１０３は、接合側部１０１の形成により筒状形状となったシートの端部の一つを熱によって融着することによって形成される。薬剤経口投与装置１００は、接合側部１０１、折れ側部１０２、及び、閉端部１０３によって、三方が閉じられた袋形状を形成する。 The closed end portion 103 is formed by fusing one of the end portions of the sheet that has been formed into a cylindrical shape by the formation of the joining side portion 101 with heat. The pharmaceutical oral administration device 100 forms a bag shape having three sides closed by the joint side portion 101, the folding side portion 102, and the closed end portion 103.
　開端部１０４は、閉端部１０３に対向して位置する。開端部１０４は、第１開端部１０４ａ及び第２開端部１０４ｂを有している。第１開端部１０４ａと第２開端部１０４ｂとは、対向して位置する。図１及び図２に示すように、第２開端部１０４ｂのみに半円状の切り欠き部１０４ｃが形成されている。これにより、切り欠き部１０４ｃを介して第１開端部１０４ａが露出するので、切り欠き部１０４ｃを介した薬剤の投入、切り欠き部１０４ｃを介した薬剤と一体となった粘性媒体の排出・投与を、容易に実施できる。 The open end 104 is positioned opposite the closed end 103. The open end 104 has a first open end 104a and a second open end 104b. The first open end 104a and the second open end 104b are positioned to face each other. As shown in FIGS. 1 and 2, a semicircular cutout 104c is formed only in the second open end 104b. As a result, the first open end 104a is exposed through the notch 104c, so that the medicine is introduced through the notch 104c and the viscous medium integrated with the medicine through the notch 104c is discharged / administered. Can be easily implemented.
　中間接合部１０５は、接合側部１０１と折れ側部１０２とを横断するように形成される。中間接合部１０５は、第１中間接合部１０５ａ及び第２中間接合部１０５ｂを有している。第１中間接合部１０５ａと第２中間接合部１０５ｂとは、ほぼ平行に形成される、また、第１中間接合部１０５ａは、第２中間接合部１０５ｂに対して、閉端部１０３側に形成される。 The intermediate joint portion 105 is formed so as to cross the joint side portion 101 and the bent side portion 102. The intermediate joint 105 includes a first intermediate joint 105a and a second intermediate joint 105b. The first intermediate joint 105a and the second intermediate joint 105b are formed substantially in parallel, and the first intermediate joint 105a is formed on the closed end 103 side with respect to the second intermediate joint 105b. Is done.
　中間接合部１０５は、粘性媒体を媒体封入部２０３（後述）に配置した後、シートを熱によって融着することによって形成される。中間接合部１０５は、携帯時、搬送時に媒体封入部２０３から粘性媒体が漏洩しないようにするとともに、使用時に媒体封入部２０３から粘性媒体を取り出しやすいように形成される。中間接合部１０５は、粘性媒体封入部２０３の内圧が所定以上高くなると融着が剥がれる程度の融着強度を持つように形成される。 The intermediate joint portion 105 is formed by placing a viscous medium in a medium sealing portion 203 (described later) and then fusing the sheet with heat. The intermediate joint 105 is formed so that the viscous medium does not leak from the medium enclosure 203 when being carried or transported, and the viscous medium can be easily taken out from the medium enclosure 203 during use. The intermediate joint portion 105 is formed so as to have a fusion strength such that the fusion is peeled off when the internal pressure of the viscous medium sealing portion 203 becomes higher than a predetermined level.
　排出口形成接合部１０６は、媒体封入部２０３と薬剤配置部２０１（後述）との間に位置し、粘性媒体を裁断する。排出口形成接合部１０６は、接合側部１０１と折れ側部１０２との間の所定の位置と折れ側部１０２とを結ぶように、開端部１０４側から閉端部１０３側に向かって下降するように形成されている。排出口形成接合部１０６の開端部１０４側の端部１０６ｔは、接合側部１０１から所定の距離だけ離れた位置に形成される。 The discharge port forming joint portion 106 is located between the medium enclosing portion 203 and a drug placement portion 201 (described later), and cuts the viscous medium. The discharge port forming joint portion 106 descends from the open end 104 side toward the closed end 103 side so as to connect a predetermined position between the joint side portion 101 and the fold side portion 102 and the fold side portion 102. It is formed as follows. An end 106t on the open end 104 side of the discharge port forming joint 106 is formed at a position away from the joint side 101 by a predetermined distance.
　排出口形成接合部１０６は、粘性媒体を排出する排出口１０６ｄを有している。排出口１０６ｄは、粘性媒体が中間接合部１０５の接合を破って媒体封入部２０３から薬剤配置部２０１に向かって移動する際に粘性媒体が通過する開口である。また、排出口形成接合部１０６は、接合側部１０１と排出口形成接合部１０６の端部１０６ｔとの間に形成される。排出口１０６ｄは、中間接合部１０５における接合側部１０１と折れ側部１０２との間の距離よりも小さい距離の開口である。 The discharge port forming joint 106 has a discharge port 106d for discharging the viscous medium. The discharge port 106d is an opening through which the viscous medium passes when the viscous medium breaks the joint of the intermediate joint portion 105 and moves from the medium sealing portion 203 toward the medicine placement portion 201. Further, the discharge port forming joint portion 106 is formed between the joint side portion 101 and the end portion 106 t of the discharge port forming joint portion 106. The discharge port 106 d is an opening having a distance smaller than the distance between the joining side portion 101 and the folding side portion 102 in the intermediate joining portion 105.
　排出口形成接合部１０６は、第１傾斜接合部１０６ａ、第２傾斜接合部１０６ｂ、及び、支持接合部１０６ｃを有している。粘性媒体は、第１傾斜接合部１０６ａ及び第２傾斜接合部１０６ｂによって形成される粘性媒体移動線Ｌ１０６に沿って移動する。第１傾斜接合部１０６ａ及び第２傾斜接合部１０６ｂは、それぞれ、開端部１０４から閉端部１０３に向かって斜めに形成されている。なお、第１傾斜接合部１０６ａと第２傾斜接合部１０６ｂとは、互いに傾斜角度が異なる。つまり、排出口形成接合部１０６は、一定の傾斜角度を有していない。第１傾斜接合部１０６ａは、第２傾斜接合部１０６ｂに比して、緩い傾斜角度を有している。また、第１傾斜接合部１０６ａは、第２傾斜接合部１０６ｂよりも、開端部１０４側に形成されている。 The discharge port forming joint 106 includes a first slope joint 106a, a second slope joint 106b, and a support joint 106c. The viscous medium moves along a viscous medium movement line L106 formed by the first inclined joint 106a and the second inclined joint 106b. The first inclined joint portion 106a and the second inclined joint portion 106b are formed obliquely from the open end portion 104 toward the closed end portion 103, respectively. The first inclined joint portion 106a and the second inclined joint portion 106b have different inclination angles. That is, the discharge port forming joint portion 106 does not have a constant inclination angle. The first inclined joint portion 106a has a gentler inclination angle than the second inclined joint portion 106b. Moreover, the 1st inclination junction part 106a is formed in the open end part 104 side rather than the 2nd inclination junction part 106b.
　このように、傾斜角度が異なる第１傾斜接合部１０６ａ及び第２傾斜接合部１０６ｂを、連続して形成することによって、排出口１０６ｄから、所定の大きさの粘性媒体を、安定して排出することができる。なお、傾斜角度が異なる傾斜接合部を連続して形成することによって、排出口１０６ｄから、所定の大きさの粘性媒体を、安定して排出することができるという知見は、実験の結果、発明者が見いだしたものである。 As described above, by continuously forming the first inclined joint portion 106a and the second inclined joint portion 106b having different inclination angles, the viscous medium having a predetermined size is stably discharged from the discharge port 106d. be able to. In addition, the inventor found that the viscous medium having a predetermined size can be stably discharged from the discharge port 106d by continuously forming the inclined joint portions having different inclination angles as a result of the experiment. Is what I found.
　支持接合部１０６ｃは、第１傾斜接合部１０６ａと第２傾斜接合部１０６ｂとの接合点付近から、折れ側部１０２までを結ぶように形成される。排出口形成接合部１０６は、排出口形成接合部１０６の端部１０６ｔは、第２中間接合部１０５ｂよりも、開端部０１４側に位置するように形成される。 The support joint portion 106c is formed so as to connect from the vicinity of the joint point between the first slope joint portion 106a and the second slope joint portion 106b to the folding side portion 102. The discharge port forming joint portion 106 is formed so that the end portion 106t of the discharge port forming joint portion 106 is located closer to the open end portion 014 than the second intermediate joint portion 105b.
　収納状態維持部１０７は、閉端部１０３に形成される。収納状態維持部１０７は、開端部１０４の幅よりも大きい切れ込みとして形成される。これにより、開端部１０４を折り曲げた収納状態（後述）における閉端部１０３とは異なる端部を、収納状態維持部１０７に容易に挿入できる。 The storage state maintaining unit 107 is formed in the closed end portion 103. The storage state maintaining portion 107 is formed as a cut larger than the width of the open end portion 104. Thereby, an end portion different from the closed end portion 103 in the storage state (described later) in which the open end portion 104 is bent can be easily inserted into the storage state maintaining portion 107.
　接合側部１０１、折れ側部１０２、及び、第２中間接合部１０５ｂによって形成される空間は、薬剤配置部２０１として機能する。薬剤配置部２０１には、所定の薬剤Ｔが配置される。配置する薬剤Ｔは、錠剤、カプセル剤、顆粒等、いずれの形状であってもよい。なお、図１においては、配置する薬剤Ｔとして、錠剤を例示している。 The space formed by the bonding side portion 101, the folding side portion 102, and the second intermediate bonding portion 105b functions as a medicine placement portion 201. A predetermined medicine T is placed in the medicine placement unit 201. The drug T to be arranged may have any shape such as a tablet, a capsule, or a granule. In addition, in FIG. 1, the tablet is illustrated as the chemical | medical agent T to arrange | position.
　接合側部１０１、折れ側部１０２、閉端部１０３、及び、第１中間接合部１０５ａによって形成される空間は、粘性媒体封入部２０３として機能する。粘性媒体封入部２０３には、所定の粘性を有し、個々の薬剤を被覆した上で、被覆した薬剤と一体化した薬剤被覆媒体を形成する粘性媒体が封入される。本実施例においては、粘性媒体として、いわゆるゼリーを用いている。粘性媒体を用いることによって、薬剤の状態では飲み込むことが難しい患者に対しても、容易に経口投与できるようになる。 The space formed by the joining side portion 101, the folding side portion 102, the closed end portion 103, and the first intermediate joining portion 105a functions as the viscous medium enclosing portion 203. In the viscous medium enclosing unit 203, a viscous medium having a predetermined viscosity and covering each individual drug and forming a drug-coated medium integrated with the coated drug is encapsulated. In this embodiment, so-called jelly is used as the viscous medium. By using a viscous medium, it can be easily administered orally even to patients who are difficult to swallow in the state of drugs.
　第１傾斜接合部１０６ａ、支持接合部１０６ｃ、及び、折れ側部１０２との間に形成される空間は、薬剤受容部２０５として機能する。薬剤受容部２０５は、薬剤経口投与装置１００を使用する際に、安定して薬剤を保持する。これにより、薬剤経口投与装置１００の使用者は、粘性媒体と薬剤とを容易に混合することができるようになる。 The space formed between the first inclined joint portion 106a, the support joint portion 106c, and the bent side portion 102 functions as the drug receiving portion 205. The drug receiving unit 205 stably holds the drug when the drug oral administration device 100 is used. Thereby, the user of the drug oral administration device 100 can easily mix the viscous medium and the drug.
第２　使用方法
　薬剤経口投与装置１００を使用する際には、錠剤Ｔ等の薬剤を薬剤配置部２０１に封入する準備段階と、薬剤被覆媒体を経口投与する経口投与段階とがある。以下に、各段階について説明する。 Second Usage Method When the drug oral administration device 100 is used, there are a preparation stage in which a drug such as a tablet T is sealed in the drug placement unit 201 and an oral administration stage in which the drug-coated medium is orally administered. Hereinafter, each stage will be described.
１．準備段階
　準備段階においては、薬剤経口投与装置１００は、粘性媒体封入部２０３に所定の粘性媒体が予め封入された状態で、薬剤を封入する使用者（以下、封入者）に提供される。以下において、薬剤経口投与装置１００の準備段階を図３～図５を用いて説明する。 1. Preparation Stage In the preparation stage, the oral medicine administration device 100 is provided to a user (hereinafter referred to as encapsulator) who encapsulates the medicine in a state where a predetermined viscous medium is encapsulated in the viscous medium enclosure 203 in advance. Hereinafter, the preparation stage of the oral drug administration device 100 will be described with reference to FIGS.
　図３に示すように、薬剤経口投与装置１００に薬剤Ｔを封入しようとする封入者は、薬剤Ｔを、開端部１０４に配置した後、矢印ａ３１方向へ移動させて、薬剤配置部２０１へ投入する。このとき、開端部１０４を菱形状に開口させる。そして、切り欠き部１０４ｃが形成されていない第１開端部１０４ａを下側に、切り欠き部１０４ｃが形成されている第２開端部１０４ｂが上側に、それぞれ位置させ、切り欠き部１０４ｃを介して第１開端部１０４ａの上に錠剤Ｔを配置する。なお、開端部１０４を菱形状に開口させているため、第１開端部１０４ａが下側に凸形状となるため、錠剤Ｔを受容しやすく、錠剤Ｔを投入する際に横にこぼす等、投入の失敗を防止できる。 As shown in FIG. 3, the encapsulator who intends to enclose the drug T in the drug oral administration device 100 arranges the drug T in the open end 104, moves it in the direction of the arrow a <b> 31, and inputs it into the drug arrangement unit 201 To do. At this time, the open end 104 is opened in a diamond shape. Then, the first open end 104a where the notch 104c is not formed is positioned on the lower side, and the second open end 104b where the notch 104c is formed is positioned on the upper side, via the notch 104c. The tablet T is arrange | positioned on the 1st open end part 104a. Since the open end 104 is opened in a diamond shape, the first open end 104a has a convex shape on the lower side. Therefore, the tablet T can be easily received, and when the tablet T is inserted, it is spilled sideways. Can prevent failure.
　錠剤Ｔの投入後、図４示すように、封入者は、開端部１０４を第２開端部１０４ｂを内側にしながら、薬剤配置部２０１方向、つまり矢印ａ４１方向に折り曲げる。これにより、薬剤経口投与装置１００を、開端部１０４を折りたたんだ２つ折りの状態とすることができる。なお、開端部１０４を折り返す際には、少なくとも切り欠き部１０４ｃが完全に内側となるような位置で折り返す。 After the tablet T is charged, as shown in FIG. 4, the encapsulator bends the medicine end portion 104 in the direction of the medicine placement portion 201, that is, the direction of the arrow a <b> 41, with the open end portion 104 facing inward. Thereby, the pharmaceutical oral administration device 100 can be in a two-fold state in which the open end 104 is folded. When the open end portion 104 is folded, it is folded at a position where at least the notch portion 104c is completely inside.
　薬剤経口投与装置１００を２つ折りにした状態から、封入者は、さらに、図５に示すように、第１中間接合部１０５ａに沿って、開端部１０４を折りたたんだ状態の薬剤配置部２０１を、粘性媒体封入部２０３方向へ、つまり矢印ａ５１方向へ折りたたんだ後、薬剤配置部２０１の第２中間接合部１０５ｂ側の端部とは異なる端部、すなわち開端部を折りたたんだ端部を、矢印ａ５３方向に沿って、収納状態維持部１０７に挿入する。これにより、薬剤経口投与装置１００を、３つ折りの状態とすることができる。これにより、薬剤経口投与装置１００を３つ折り状態とすることによって、コンパクトに収納できるとともに、携帯時の形態を安定させることができる。 From the state where the drug oral administration device 100 is folded in half, the encapsulator further moves the drug placement part 201 in a state where the open end part 104 is folded along the first intermediate joint part 105a as shown in FIG. After folding in the direction of the viscous medium enclosing portion 203, that is, in the direction of the arrow a51, an end different from the end on the second intermediate joint portion 105b side of the drug placement portion 201, that is, an end where the open end is folded is indicated by an arrow a53. It inserts in the accommodation state maintenance part 107 along a direction. Thereby, the chemical | medical agent oral administration apparatus 100 can be made into a three-fold state. Thereby, by making medicine oral administration device 100 into a folded state, while being compactly packable, the form at the time of carrying can be stabilized.
２．経口投与段階
　次に、薬剤経口投与装置１００の経口投与段階を図６、図７を用いて説明する。なお、図６においては、中間接合部１０５の記載を省略している。 2. Oral Administration Stage Next, the oral administration stage of the drug oral administration device 100 will be described with reference to FIGS. In FIG. 6, the description of the intermediate joint 105 is omitted.
　薬剤経口投与装置１００に収納されている薬剤を自ら経口する、又は、他の者に経口させる経口投与者は、図５に示すような３つ折り状態とされた薬剤経口投与装置１００を、図６に示すような平面状態とする。 The oral administration person who orally administers the medicine stored in the medicine oral administration device 100 or makes it oral by the other person shows the medicine oral administration device 100 in a trifolded state as shown in FIG. As shown in FIG.
　図６に示すような平面状態において、経口投与者は、粘性媒体封入部２０３を指で圧迫する。これにより、粘性媒体封入部２０３の内部の圧力が高くなる。粘性媒体封入部２０３の内圧が所定以上高くなると、中間接合部１０５の融着が剥がれ、媒体封入部２０３の内部に位置する粘性媒体が、薬剤配置部２０１の方向へ移動する。 In the planar state as shown in FIG. 6, the oral administration person presses the viscous medium enclosing portion 203 with a finger. As a result, the pressure inside the viscous medium enclosure 203 increases. When the internal pressure of the viscous medium enclosing part 203 becomes higher than a predetermined level, the fusion bonding of the intermediate joint part 105 is peeled off, and the viscous medium located inside the medium enclosing part 203 moves in the direction of the medicine placement part 201.
　このとき、粘性媒体は、排出口形成接合部１０６の第２傾斜接合部１０６ｂ、及び、第１傾斜接合部１０６ａに沿って矢印ａ６１方向から矢印ａ６５方向に排出される。つまり、粘性媒体は、粘性媒体移動線Ｌ１０６に沿って移動する。粘性媒体は、中間接合部１０５から、排出口１０６ｄは、中間接合部１０５における接合側部１０１と折れ側部１０２との間の距離よりも小さい距離の開口である排出口１０６ｄに向かって移動する。このため、粘性媒体は、粘性媒体封入部２０３に加えられた圧迫の力、つまり、粘性媒体が広い媒体封入部２０１から狭い排出口１０６ｄへ向かう際に粘性媒体に加えられる圧力や、粘性媒体自身の粘性等の特性によって、適度な大きさに裁断される。なお、粘性媒体は、接合側部１０１の傾斜側部１０１ａに沿って矢印ａ６３方向にも排出される。このため、粘性媒体は、矢印ａ６１方向及び矢印ａ６３方向の交点付近で合流することから、より裁断が促進される。 At this time, the viscous medium is discharged from the arrow a61 direction to the arrow a65 direction along the second inclined joint portion 106b and the first inclined joint portion 106a of the discharge port forming joint portion 106. That is, the viscous medium moves along the viscous medium movement line L106. The viscous medium moves from the intermediate joint portion 105 toward the discharge port 106d, which is an opening having a distance smaller than the distance between the joint side portion 101 and the folding side portion 102 in the intermediate joint portion 105. . For this reason, the viscous medium is a compression force applied to the viscous medium enclosure 203, that is, the pressure applied to the viscous medium when the viscous medium is directed from the wide medium enclosure 201 to the narrow discharge port 106d, or the viscous medium itself. Depending on the viscosity and other characteristics, the material is cut into an appropriate size. The viscous medium is also discharged in the direction of the arrow a63 along the inclined side portion 101a of the joining side portion 101. For this reason, since a viscous medium merges in the vicinity of the intersection of the arrow a61 direction and the arrow a63 direction, cutting is further promoted.
　裁断された粘性媒体は、排出口１０６ｄから矢印ａ６７に沿うかたちで、薬剤配置部２０１に排出される。なお、薬剤配置部２０１に排出される際には、裁断された粘性媒体は、薬剤受容部２０５側に排出される。薬剤受容部２０５には薬剤Ｔが位置しているため、裁断された粘性媒体と薬剤Ｔとを容易に一体とできる。これにより、薬剤配置部２０１の内部に位置する薬剤Ｔ及び粘性媒体が一体となった薬剤被覆媒体を生成できる。なお、薬剤Ｔと粘性媒体とを揉み込むようにすることによって、粘性媒体に薬剤が均一に包含された薬剤被覆媒体を生成できる。 The cut viscous medium is discharged from the discharge port 106d to the medicine placement unit 201 along the arrow a67. When discharged to the medicine placement unit 201, the cut viscous medium is discharged to the medicine receiving unit 205 side. Since the medicine T is located in the medicine receiving part 205, the cut viscous medium and the medicine T can be easily integrated. Thereby, the medicine covering medium in which the medicine T and the viscous medium located inside the medicine placement unit 201 are integrated can be generated. In addition, by swallowing the drug T and the viscous medium, a drug-coated medium in which the drug is uniformly included in the viscous medium can be generated.
　薬剤被覆媒体を生成した後、図７に示すように、薬剤被覆媒体を開端部１０４方向、つまり矢印ａ７１方向へ移動させ、薬剤被覆媒体を第１開端部１０４ａ上に配置する。そして、第１開端部１０４ａから薬剤被覆媒体を経口投与する。 After the drug-coated medium is generated, as shown in FIG. 7, the drug-coated medium is moved in the direction of the open end 104, that is, in the direction of the arrow a71, and the drug-coated medium is disposed on the first open end 104a. Then, the drug-coated medium is orally administered from the first open end 104a.
［その他の実施例］
　（１）粘性媒体　：　前述の実施例１においては、粘性媒体として、いわゆるゼリーを用いたが、所定の粘度、所定の強度を有し、薬剤を被覆し、被覆された複数の薬剤が一体となった薬剤被覆媒体を形成するものであれば例示のものに限定されない。 [Other Examples]
(1) Viscous medium: In Example 1 described above, so-called jelly was used as the viscous medium. However, the viscous medium has a predetermined viscosity and a predetermined strength, is coated with a drug, and a plurality of coated drugs are integrated. The present invention is not limited to the examples as long as the formed drug-coated medium is formed.
　（２）薬剤　：　前述の実施例１においては、薬剤として錠剤Ｔを示したが、薬剤であれば例示のものに限定されない。例えば、ミニタブレット、ペレット、ハードカプセル、ソフトカプセル、包蔵物、顆粒、粉剤、ＡＰＩであってもよい。 (2) Drug: In Example 1 described above, tablet T is shown as the drug, but the drug is not limited to the illustrated one as long as it is a drug. For example, it may be a mini tablet, pellet, hard capsule, soft capsule, inclusion, granule, powder, API.
　また、薬剤の代わりに、所定の栄養素を補給するためのものであるサプリメントを用いるようにしてもよい。 Further, a supplement for supplementing a predetermined nutrient may be used instead of the drug.
　（３）材質　：　前述の実施例１薬剤経口投与装置１００を形成するシートの材質としてポリプロピレン等を示したが、接合側部１０１、中間接合部１０５、排出口形成接合部１０６を形成できるものであれば、例示のものに限定されない。例えば、アルミニウム等、軟質の材料によって形成するようにしてもよい。また、透明、半透明であってもよい。 (3) Material: Although polypropylene or the like is shown as the material of the sheet forming the above-described Example 1 drug oral administration device 100, the joint side portion 101, the intermediate joint portion 105, and the discharge port forming joint portion 106 can be formed. If there is, it is not limited to the example. For example, you may make it form with soft materials, such as aluminum. Further, it may be transparent or translucent.
　（４）収納状態維持部１０７　：　前述の実施例１においては、閉端部１０３に形成する切り込みによって収納状態維持部１０７を構成するとしたが、薬剤経口投与装置を折りたたんだ収納状態を維持できるものであれば、例示のものに限定されない。例えば、図８に示す薬剤経口投与装置３００に示すように、接合端部１０３に連続する形で、粘性媒体封入部２０３とは異なる方向に、収納状態維持部３０７を形成するようにしてもよい。 (4) Storage state maintenance unit 107: In Example 1 described above, the storage state maintenance unit 107 is configured by the cut formed in the closed end portion 103. However, the storage state in which the oral medicine administration device is folded can be maintained. If it is, it is not limited to the thing of illustration. For example, as shown in the oral medicine administration device 300 shown in FIG. 8, the storage state maintaining unit 307 may be formed in a direction that is continuous with the joint end 103 and in a direction different from the viscous medium enclosing unit 203. .
　収納状態維持部３０７は、接合端部１０３に対向して位置する端部収納用開口を有している。図９に示すように、開端部１０４を折りたたんだ状態で、薬剤配置部２０３を粘性媒体封入部２０３に重なるように折りたたむ。また、収納状態維持部３０７も粘性媒体封入部２０３に重なるように折りたたむ。そして、折りたたんだ薬剤配置部２０３の一端を、収納状態維持部３０７の端部収納用開口に挿入し、携行時における薬剤経口投与装置３００の収納状態を維持する。 The storage state maintaining unit 307 has an end storage opening that is positioned opposite to the joint end 103. As shown in FIG. 9, with the open end portion 104 folded, the drug placement portion 203 is folded so as to overlap the viscous medium enclosing portion 203. The storage state maintaining unit 307 is also folded so as to overlap the viscous medium enclosing unit 203. Then, one end of the folded drug placement unit 203 is inserted into the end storage opening of the storage state maintaining unit 307, and the storage state of the drug oral administration device 300 during carrying is maintained.
　また、図１０に示す薬剤経口投与装置４００のように、側部接合領域１０１ｒに形成される収納状態維持部４０７によって収納状態を維持するようにしてもよい。収納状態維持部４０７は、薬剤配置部２０３に対応する接合側部１０１に形成される第１切り欠き４０７ａ、第２切り欠き４０７ｂ、及び、粘性媒体封入部２０３に対応する接合側部１０１に形成される第３切り欠き４０７ｃ、第４切り欠き４０７ｄを有している。第１切り欠き４０７ａ、第２切り欠き４０７ｂは、接合側部１０１の端から薬剤配置部２０３に向かって狭くなる切れ込みとして形成される。一方、第３切り欠き４０７ｃ、第４切り欠き４０７ｄは、接合側部１０１の端から粘性媒体封入部２０３に向かって広くなる切れ込みとして形成される。 Further, as in the oral drug administration device 400 shown in FIG. 10, the storage state may be maintained by the storage state maintaining unit 407 formed in the side joint region 101r. The storage state maintaining unit 407 is formed in the first cutout 407a, the second cutout 407b formed in the bonding side portion 101 corresponding to the medicine placement portion 203, and the bonding side portion 101 corresponding to the viscous medium enclosing portion 203. The third cutout 407c and the fourth cutout 407d are provided. The first cutout 407 a and the second cutout 407 b are formed as cuts that become narrower from the end of the joining side portion 101 toward the drug placement portion 203. On the other hand, the third cutout 407 c and the fourth cutout 407 d are formed as cuts that widen from the end of the joining side portion 101 toward the viscous medium sealing portion 203.
　携行時における収納状態を形成する際には、図１１Ａに示すように、開端部１０４を折りたたんだ状態で、図１１Ａに示すＸ領域を拡大した図１１Ｂに示すように、第１切り欠き４０７ａ、第２切り欠き４０７ｂの先端の一部を、第３切り欠き４０７ｃ、第４切り欠き４０７ｄに挿入し、第１切り欠き４０７ａ、第２切り欠き４０７ｂを、第３切り欠き４０７ｃ、第４切り欠き４０７ｄに係合させる。これにより、薬剤経口投与装置４００を収納状態に維持できる。なお、図１１Ｂにおいては、第１切り欠き４０７ａ、第２切り欠き４０７ｂの斜線部分が、第３切り欠き４０７ｃ、第４切り欠き４０７ｄに係合させた部分を示している。 When forming the storage state during carrying, as shown in FIG. 11A, the first notch 407a, as shown in FIG. 11B in which the X region shown in FIG. A part of the tip of the second notch 407b is inserted into the third notch 407c and the fourth notch 407d, and the first notch 407a and the second notch 407b are inserted into the third notch 407c and the fourth notch. 407d is engaged. Thereby, the medicine oral administration device 400 can be maintained in the housed state. In FIG. 11B, the hatched portions of the first cutout 407a and the second cutout 407b show the portions engaged with the third cutout 407c and the fourth cutout 407d.
　　（５）排出口形成接合部１０６の形状　：　前述の実施例１における薬剤経口投与装置１００では、排出口形成接合部１０６は、傾斜角度の異なる第１傾斜接合部１０６ａ及び第２傾斜接合部１０６ｂを有するとしたが、傾斜角度が一定でないものであれば、例示のものに限定されない。例えば、図１２に示す薬剤経口投与装置５００、円弧形状の排出口形成接合部５０６を形成するようにしてもよい。この場合、円弧状の排出口形成接合部５０６によって粘性媒体移動線Ｌ５０６が形成される。 (5) Shape of the discharge port forming joint portion 106: In the oral drug administration device 100 in Example 1 described above, the discharge port forming joint portion 106 includes the first inclined joint portion 106a and the second inclined joint portion 106b having different inclination angles. However, the present invention is not limited to the example as long as the inclination angle is not constant. For example, you may make it form the chemical | medical agent oral administration apparatus 500 shown in FIG. 12, and the circular arc shaped discharge port formation junction part 506. FIG. In this case, the viscous medium moving line L506 is formed by the arc-shaped discharge port forming joint 506.
　また、図１３に示す薬剤経口投与装置５５０のように、前述の実施例１における薬剤経口投与装置１００の第１傾斜接合部１０６ａ及び第２傾斜接合部１０６ｂを複数に分割した分割した分割傾斜接合部２０６ａ～２０６ｄを形成するようにしてもよい。この場合、各分割接合部間の間隔は、粘性媒体が隙間から漏れ出ることなく、各分割接合部にそって移動できるような距離とすればよい。この場合、粘性媒体は分割傾斜接合部２０６ａ～２０６ｄに沿って移動するため、分割傾斜接合部２０６ａ～２０６ｄ及びその間の空間によって粘性媒体移動線Ｌ６０６が形成される。 Further, as in the oral medicine administration device 550 shown in FIG. 13, the divided inclined joint obtained by dividing the first inclined joint portion 106a and the second inclined joint portion 106b of the oral medicine administration device 100 in Example 1 described above into a plurality of parts. The portions 206a to 206d may be formed. In this case, the distance between the divided joints may be a distance that allows the viscous medium to move along the respective divided joints without leaking from the gap. In this case, since the viscous medium moves along the divided inclined joints 206a to 206d, the viscous medium movement line L606 is formed by the divided inclined joints 206a to 206d and the space therebetween.
　（６）支持接合部１０６ｃ：前述の実施例１における薬剤経口投与装置１００では、排出口形成接合部１０６は、支持接合部１０６ｃを有するとしたが、図１４に示す薬剤経口投与装置６００のように、支持接合部１０６ｃを形成しないようにしてもよい。また、図１に示す支持接合部１０６ｃと第２傾斜接合部１０６ｂとの間の空間を融着するようにし、第１傾斜接合部１０６ａ、第２傾斜接合部１０６ｂ、及び、支持接合部１０６ｃを、一体的に融着するようにしてもよい。 (6) Support joint 106c: In the drug oral administration device 100 in the first embodiment described above, the discharge port forming joint 106 has the support joint 106c, but like the drug oral administration device 600 shown in FIG. In addition, the support joint 106c may not be formed. Also, the space between the support joint 106c and the second inclined joint 106b shown in FIG. 1 is fused, and the first inclined joint 106a, the second inclined joint 106b, and the support joint 106c are connected. , And may be integrally fused.
　（７）側部接合領域１０１ｒ：前述の実施例１における薬剤経口投与装置１００では、側部接合領域１０１ｒにおける接合側部１０１と外部側部１０１ｅとは平行に形成されるとしたが、所定の形状の接合側部１０１を形成できるものであれば、例示のものに限定されない。例えば、図１５に示す薬剤経口投与装置６５０のように、外部側部６５１ｅを接合側部１０１とは異なる水平形状である側部接合領域６５１ｒを形成するようにしてもよい。 (7) Side joint region 101r: In the oral drug administration device 100 in Example 1 described above, the joint side portion 101 and the external side portion 101e in the side joint region 101r are formed in parallel. The shape is not limited to the illustrated example as long as the joining side portion 101 having a shape can be formed. For example, as in the oral medicine administration device 650 shown in FIG. 15, the outer side portion 651 e may be formed with a side joining region 651 r having a horizontal shape different from that of the joining side portion 101.
　（８）傾斜側部１０１ａ：前述の実施例１における薬剤経口投与装置１００では、接合側部１０１は傾斜側部１０１ａを有するとしたが、図１６に示す薬剤経口投与装置７００のように、傾斜側部を有さない接合側部７０１を形成するようにしてもよい。この場合、接合側部７０１は、側部接合領域７０１ｒの折れ側部１０２の側の境界に、開端部１０４の一つの端部１０４Ｔ１と、対応する閉端部７０３の一つの端部７０３Ｔ１とを結んで、直線上に形成される。なお、折れ側部１０２は、接合側部１０１を形成することによって筒状形状としたシートを平面形状に圧接することによって形成される境界に、開端部１０４の一つの端部１０４Ｔ２と、対応する閉端部７０３の一つの端部７０３Ｔ２とを結んで、直線上に形成される。 (8) Inclined side portion 101a: In the drug oral administration device 100 in the above-described first embodiment, the joint side portion 101 has the inclined side portion 101a. However, as in the drug oral administration device 700 shown in FIG. You may make it form the joining side part 701 which does not have a side part. In this case, the joining side portion 701 includes one end portion 104T1 of the open end portion 104 and one end portion 703T1 of the corresponding closed end portion 703 at the boundary of the side joining region 701r on the folded side portion 102 side. Connected to form a straight line. The folded side portion 102 corresponds to one end portion 104T2 of the open end portion 104 at a boundary formed by press-contacting a sheet having a cylindrical shape by forming the joining side portion 101 into a planar shape. It is formed on a straight line connecting one end portion 703T2 of the closed end portion 703.
　（９）薬剤経口投与装置１００の筒状形状：前述の実施例１における薬剤経口投与装置１００では、１枚のシートの端部を融着し、図１に示すように、一方の側部に接合側部１０１を形成することによって薬剤経口投与装置１００を筒状形状としたが、筒状形状とできるものであれば、例示のものに限定されない。例えば、２枚のシートの両端部を融着し、図１７に示す薬剤経口投与装置８００のように、一方の側部に接合側部１０１を形成し、もう一方の側部にも接合側部８０２を形成するようにしてもよい。 (9) Cylindrical shape of the drug oral administration device 100: In the drug oral administration device 100 in Example 1 described above, the end of one sheet is fused and, as shown in FIG. Although the oral medicine administration device 100 has a cylindrical shape by forming the joint side portion 101, it is not limited to the illustrated one as long as it can have a cylindrical shape. For example, both ends of two sheets are fused, and a joining side portion 101 is formed on one side as in the oral medicine administration device 800 shown in FIG. 802 may be formed.
　（１０）中間接合部１０５：前述の実施例１においては、中間接合部１０５は、第１中間接合部１０５ａ及び第２中間接合部１０５ｂを有するとしたが、いずれか一方だけを形成するようにしてもよい。また、３つ以上の中間接合部を形成するようにしてもよい。 (10) Intermediate joint 105: In the first embodiment, the intermediate joint 105 has the first intermediate joint 105a and the second intermediate joint 105b, but only one of them is formed. May be. Three or more intermediate joints may be formed.
　（１１）排出口形成部：前述の実施例１においては、排出口傾斜接合部１０６によって、粘性媒体を裁断する粘性媒体裁断部を形成するとしたが、排出口傾斜接合部１０６を形成せずに、粘性媒体裁断部を形成するようにしてもよい。例えば、図１８に示す薬剤経口投与装置８００のように、媒体封入部２０３と薬剤配置部２０１との間に位置する排出口形成部８０６を形成する。排出口形成部８０６は、対向して位置する形成材を島状に融着することによって形成される。排出口形成部８０６は、排出口形成傾斜接合部８０６ａ、８０６ｂによって構成される。粘性媒体が中間接合部１０５の接合を破って媒体封入部２０３から薬剤配置部２０１に向かって移動する際に、粘性媒体は、排出口形成傾斜接合部８０６ａ、８０６ｂによって形成される排出口８０６ｄ１～８０６ｄ３を通過する。なお、排出口８０６ｄ１～８０６ｄ３は、それぞれ、中間接合部１０５における接合側部１０１と折れ側部１０２との間の距離よりも小さい距離の開口により形成される。 (11) Discharge port forming portion: In the above-described first embodiment, the discharge port inclined joint portion 106 forms the viscous medium cutting portion that cuts the viscous medium, but the discharge port inclined joint portion 106 is not formed. Alternatively, a viscous medium cutting part may be formed. For example, like the drug oral administration device 800 shown in FIG. 18, the discharge port forming unit 806 located between the medium enclosing unit 203 and the drug placement unit 201 is formed. The discharge port forming part 806 is formed by fusing the forming materials positioned opposite to each other in an island shape. The discharge port forming portion 806 is configured by discharge port forming inclined joint portions 806a and 806b. When the viscous medium breaks the joint of the intermediate joint portion 105 and moves from the medium sealing portion 203 toward the drug placement portion 201, the viscous medium is discharged from the discharge ports 806d1 to 806d1˜ formed by the discharge port forming inclined joint portions 806a and 806b. Pass 806d3. The discharge ports 806d1 to 806d3 are each formed by an opening having a distance smaller than the distance between the bonding side portion 101 and the folding side portion 102 in the intermediate bonding portion 105.
　（１２）排出口：前述の実施例１において、薬剤経口投与装置１００は、一つの排出口１０６ｄを有するとしたが、複数の排出口を有してもよい。例えば、図１９に示す薬剤経口投与装置９００ように、島状接合部９０６ａを有し、島状接合部９０６ａの上、下、それぞれに１つ、合計２つの排出口９０６ｄ１、９０６ｄ２を有する排出口形成部９０６を形成するようにしてもよい。 (12) Discharge port: In Example 1 described above, the oral drug administration device 100 has one discharge port 106d, but may have a plurality of discharge ports. For example, like a drug oral administration device 900 shown in FIG. 19, the discharge port has an island-shaped joint 906a, and has two discharge ports 906d1 and 906d2 in total, one above and below the island-shaped joint 906a. The forming unit 906 may be formed.
　（１３）薬剤経口投与装置の形状：前述の実施例１においては、薬剤経口投与装置１００は、接合側部１０１、折れ属部１０２、及び、閉端部１０３によって三方が閉じられた筒形状を有するとしたが、三方が閉じられた袋形状であれば、例示のものに限定されない。例えば、図２０に示すように、薬剤経口投与装置１０００の外形を、魚形状としてもよい。
(13) Shape of Oral Drug Administration Device: In Example 1 described above, the oral drug administration device 100 has a cylindrical shape in which three sides are closed by the joint side portion 101, the bent portion 102, and the closed end portion 103. However, the present invention is not limited to the illustrated example as long as the bag shape is closed on three sides. For example, as shown in FIG. 20, the outer shape of the oral drug administration device 1000 may be a fish shape.
　本発明は、薬剤と粘性媒体とを分離した状態で収納して、携行可能とし、経口投与する際に、粘性媒体及び薬剤によって形成される薬剤被覆媒体を形成して、経口投与する薬剤経口投与装置として利用できる。
The present invention stores a drug and a viscous medium in a separated state so that they can be carried, and when orally administered, a drug-coated medium formed by the viscous medium and the drug is formed and orally administered. Can be used as a device.
１００・・・・・薬剤経口投与装置
１０１・・・・・接合側部
　１０１ａ・・・傾斜側部
１０２・・・・・折れ側部
１０３・・・・・閉端部
１０４・・・・・開端部
　１０４ａ・・・第１開端部
　１０４ｂ・・・第２開端部
　１０４ｃ・・・部
１０５・・・・・中間接合部
　１０５ａ・・・第１中間接合部
　１０５ｂ・・・第２中間接合部
１０６・・・・・排出口形成接合部
　１０６ａ・・・第１傾斜接合部
　１０６ｂ・・・第２傾斜接合部
　１０６ｃ・・・支持接合部
　１０６ｄ・・・排出口
　１０６ｔ・・・端部
　Ｌ１０６ｄ・・粘性媒体移動線
１０７・・・・・収納状態維持部
２０１・・・・・薬剤配置部
２０３・・・・・粘性媒体封入部
２０５・・・・・薬剤受容部
３００・・・・・薬剤経口投与装置
３０７・・・・・収納状態維持部
４００・・・・・薬剤経口投与装置
４０７・・・・・収納状態維持部
４０７ａ・・・第１切り欠き
４０７ｂ・・・第２切り欠き
４０７ｃ・・・第３切り欠き
４０７ｄ・・・第４切り欠き
５００・・・・・薬剤経口投与装置
５０６・・・・・排出口形成接合部
６００・・・・・薬剤経口投与装置
７００・・・・・薬剤経口投与装置
７０１・・・・・接合側部
８００・・・・・薬剤経口投与装置
８０２・・・・・接合側部
９００・・・・・薬剤経口投与装置
１０００・・・・薬剤経口投与装置 DESCRIPTION OF SYMBOLS 100 ... Oral medicine administration apparatus 101 ... Joint side part 101a ... Inclined side part 102 ... Folding side part 103 ... Closed end part 104 ... Open end 104a ... 1st open end 104b ... 2nd open end 104c ... 105 ... Intermediate joint 105a ... 1st intermediate joint 105b ... 2nd intermediate joint 106... Discharge port forming joint 106 a... First inclined joint 106 b... Second inclined joint 106 c... Support joint 106 d.・ Viscous medium moving line 107... Storage state maintaining unit 201... Drug placement unit 203... Viscous medium enclosing unit 205. Oral administration device 307 ··· Storage state maintaining unit 400 ··· Oral medicine administration device 407... Storage state maintaining unit 407a... First cutout 407b... Second cutout 407c... Third cutout 407d. ··· Oral medicine administration device 506 ··· Drain formation joint portion 600 ··· Oral medicine administration device 700 ··· Oral medicine administration device 701 ··· Joint side portion 800 ··· ··· Oral drug administration device 802 ··· Joint side portion 900 ··· Oral drug administration device 1000 ······ Oral drug administration device

Claims (10)

  1. 　平面形状の所定の形成材によって形成され、開口を有する開端部、及び、閉じられた閉端部であって、前記開端部に対向して位置する閉端部、及び、前記開端部と前記閉端部の対応する端点を結んで形成される第１側部及び第２側部を有し、三方が閉じられた袋形状を有する薬剤類経口投与装置であって、
    　薬剤、及び、所定の栄養素を補給するためのサプリメントを含む薬剤類を被覆するための粘性媒体であって、被覆した前記薬剤類と一体化した薬剤被覆媒体を形成する粘性媒体、
    　前記第１側部と前記第２側部とを結ぶように形成され、対向して位置する前記形成材の接合により形成される中間接合部であって、所定以上の圧力により前記接合が破れる中間接合部、
    　前記中間接合部、前記側部、及び、前記閉端部によって形成される空間であって、前記粘性媒体を封入する粘性媒体封入部、
    　前記粘性媒体封入部からみて、前記中間接合部を介して前記粘性媒体封入部から前記開端部向かう方向に位置する薬剤配置部、
    　前記粘性媒体封入部と前記薬剤配置部との間に位置し、前記粘性媒体を裁断する粘性媒体裁断部であって、前記粘性媒体が前記中間接合部の接合を破って前記粘性媒体封入部から前記薬剤配置部に向かって移動する際に前記粘性媒体が通過する排出口であって、前記中間接合部における前記第１側部と前記第２側部との間の距離よりも小さい距離の開口である排出口を有する粘性媒体裁断部、
    　を有する薬剤類経口投与装置。     An open end portion having an opening and a closed closed end portion formed of a predetermined forming material having a planar shape, the closed end portion facing the open end portion, and the open end portion and the closed end portion. A pharmaceutical oral administration device having a first side part and a second side part formed by connecting corresponding end points of end parts and having a bag shape closed on three sides,
    A viscous medium for coating a drug and a drug containing a supplement for supplementing a predetermined nutrient, forming a drug-coated medium integrated with the coated drug,
    An intermediate joint portion formed by joining the forming materials formed so as to connect the first side portion and the second side portion and facing each other, wherein the joint is broken by a predetermined pressure or more. Junction,
    A viscous medium enclosing part for enclosing the viscous medium, which is a space formed by the intermediate joint part, the side part, and the closed end part;
    A drug placement unit located in a direction from the viscous medium enclosure to the open end via the intermediate joint as viewed from the viscous medium enclosure;
    A viscous medium cutting unit that is located between the viscous medium enclosing unit and the drug placement unit and that cuts the viscous medium, wherein the viscous medium breaks the connection of the intermediate joint and is separated from the viscous medium enclosing unit. A discharge port through which the viscous medium passes when moving toward the medicine placement portion, and an opening having a distance smaller than the distance between the first side portion and the second side portion in the intermediate joint portion A viscous medium cutting part having a discharge port,
    A device for oral administration of drugs.
  2. 　請求項１に係る薬剤類経口投与装置において、
    　前記粘性媒体裁断部は、
    　前記第１側部と前記第２側部との間の所定の端部位置から、前記開端部から前記閉端部に向かって形成され、対向して位置する前記形成材の接合により形成される排出口形成接合部であって、前記端部位置から前記第１側部又は前記第２側部との間に形成される前記排出口を前記中間接合部よりも前記開端部側に形成する排出口形成接合部、
    　を有すること、
    を特徴とする薬剤類経口投与装置。     In the pharmaceutical oral administration device according to claim 1,
    The viscous medium cutting part is
    It is formed from a predetermined end portion position between the first side portion and the second side portion from the open end portion toward the closed end portion, and is formed by joining the forming materials positioned opposite to each other. A discharge port forming joint portion, wherein the discharge port formed between the end position and the first side portion or the second side portion is formed closer to the open end portion side than the intermediate joint portion. Outlet forming joint,
    Having
    An oral administration device for pharmaceuticals.
  3. 　請求項２に係る薬剤類経口投与装置において、
    　前記排出口形成接合部は、
    　前記粘性媒体が移動する際に沿う粘性媒体移動線であって、前記開端部から前記閉端部に向かって斜めに形成され、一定した傾斜角度を有さない粘性媒体移動線を有すること、
    　を特徴とする薬剤類経口投与装置。     In the pharmaceutical oral administration device according to claim 2,
    The discharge port forming joint is
    A viscous medium movement line along which the viscous medium moves, and has a viscous medium movement line formed obliquely from the open end portion toward the closed end portion and having no constant inclination angle;
    An oral administration device for pharmaceuticals.
  4. 　請求項１～請求項３に係るいずれかの薬剤類経口投与装置において、
    　前記第２側部は、
    　前記開端部から前記閉端部に向かって斜めに形成される傾斜側部であって、前記排出口形成接合部に対向する位置に形成される傾斜側部、
    　を有する薬剤類経口投与装置。     In any of the pharmaceutical oral administration devices according to claims 1 to 3,
    The second side is
    An inclined side portion formed obliquely from the open end portion toward the closed end portion, the inclined side portion formed at a position facing the discharge port forming joint portion,
    A device for oral administration of drugs.
  5. 　請求項１～請求項４に係るいずれかの薬剤類経口投与装置において、
    　前記開端部は、
    対向して位置する前記形成材のいずれか一方の前記形成材に、他方の前記形成材を露出する切り欠き有すること、
    　を特徴とする薬剤類経口投与装置。     In any one of the pharmaceutical oral administration devices according to claims 1 to 4,
    The open end is
    Having a notch that exposes the other forming material in the forming material of any one of the forming materials positioned facing each other;
    An oral administration device for pharmaceuticals.
  6. 　請求項１～請求項６に係るいずれかの薬剤類経口投与装置において、さらに、
    　前記開端部を少なくとも１回、前記閉端部側に折りたたんだ収納状態を維持する収納状態維持部、
    　を有する薬剤類経口投与装置。     In any of the pharmaceutical oral administration devices according to claims 1 to 6,
    A storage state maintaining unit that maintains a storage state in which the open end is folded at least once toward the closed end;
    A device for oral administration of drugs.
  7. 　請求項６に係る薬剤類経口投与装置において、
    　前記収納状態維持部は、
    　前記閉端部に形成される切れ込みであること、
    　を特徴とする薬剤類経口投与装置。     In the pharmaceutical oral administration device according to claim 6,
    The storage state maintaining unit is
    A notch formed in the closed end,
    An oral administration device for pharmaceuticals.
  8. 　請求項７に係る薬剤類経口投与装置において、
    　前記収納状態維持部は、
    　前記粘性媒体封入部とは反対側に前記閉端部から連続して形成され、前記閉端部側とは異なる端部が、前記収納状態における前記閉端部とは異なる端部を収納するために開口していること、
    　を特徴とする薬剤類経口投与装置。     In the pharmaceutical oral administration device according to claim 7,
    The storage state maintaining unit is
    In order to house the end different from the closed end in the stowed state, the end being formed continuously from the closed end on the side opposite to the viscous medium enclosing part, and different from the closed end side That is open to the
    An oral administration device for pharmaceuticals.
  9. 　請求項７に係る薬剤類経口投与装置において、
    　前記収納状態維持部は、
    　前記第１側部及び／又は前記第２側部に形成され、前記中間接合部に対して前記開端部側に形成される切れ込みと、前記中間接合部に対して前記閉端部側に形成される切れ込みとを、互いに係合させるものであること、
    　を特徴とする薬剤類経口投与装置。     In the pharmaceutical oral administration device according to claim 7,
    The storage state maintaining unit is
    Formed on the first side part and / or the second side part, formed on the open end side with respect to the intermediate joint part, and formed on the closed end side with respect to the intermediate joint part. The slits are engaged with each other,
    An oral administration device for pharmaceuticals.
  10. 　請求項１～請求項９に係るいずれかの薬剤類経口投与装置において、
    　所定の前記薬剤類、
    　を有する薬剤類経口投与装置。     In any of the pharmaceutical oral administration devices according to claims 1 to 9,
    Predetermined said drugs,
    A device for oral administration of drugs.
PCT/JP2013/083958 2013-12-18 2013-12-18 P.o. medicine administration device WO2015092888A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
PCT/JP2013/083958 WO2015092888A1 (en) 2013-12-18 2013-12-18 P.o. medicine administration device
JP2015553279A JP6168160B2 (en) 2013-12-18 2013-12-18 Drug oral administration device
TW103138906A TWI662959B (en) 2013-12-18 2014-11-10 Pharmacy oral medication device

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2013/083958 WO2015092888A1 (en) 2013-12-18 2013-12-18 P.o. medicine administration device

Publications (1)

Publication Number Publication Date
WO2015092888A1 true WO2015092888A1 (en) 2015-06-25

Family

ID=53402283

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2013/083958 WO2015092888A1 (en) 2013-12-18 2013-12-18 P.o. medicine administration device

Country Status (3)

Country Link
JP (1) JP6168160B2 (en)
TW (1) TWI662959B (en)
WO (1) WO2015092888A1 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6811338B1 (en) * 1999-10-08 2004-11-02 The Procter & Gamble Company Disposable semi-enclosed applicator for distributing a substance onto a target surface
JP2011194048A (en) * 2010-03-19 2011-10-06 Jms Co Ltd Medical container
WO2011122640A1 (en) * 2010-03-29 2011-10-06 株式会社モリモト医薬 Container for orally ingested pharmaceutical composition
WO2012150704A1 (en) * 2011-05-02 2012-11-08 株式会社モリモト医薬 Container for administering medication

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4776589B2 (en) * 2007-06-19 2011-09-21 敏彦 仁科 Auxiliary container for drug use
JP3173017U (en) * 2011-11-01 2012-01-19 葉子 斉藤 Drug taking device

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6811338B1 (en) * 1999-10-08 2004-11-02 The Procter & Gamble Company Disposable semi-enclosed applicator for distributing a substance onto a target surface
JP2011194048A (en) * 2010-03-19 2011-10-06 Jms Co Ltd Medical container
WO2011122640A1 (en) * 2010-03-29 2011-10-06 株式会社モリモト医薬 Container for orally ingested pharmaceutical composition
WO2012150704A1 (en) * 2011-05-02 2012-11-08 株式会社モリモト医薬 Container for administering medication

Also Published As

Publication number Publication date
JPWO2015092888A1 (en) 2017-03-16
TW201532601A (en) 2015-09-01
TWI662959B (en) 2019-06-21
JP6168160B2 (en) 2017-07-26

Similar Documents

Publication Publication Date Title
KR100654894B1 (en) Multiple-chamber medical container and bag for enclosing same
JP2021112585A (en) Enteral feeding device
EP2702976B1 (en) Container for administering medication
US20050055013A1 (en) Medication delivery device
TW200911643A (en) Multi-compartment package
EP1838272B1 (en) Medical liquid container and preparation-containing medical liquid container
US9902508B2 (en) Delivery device with separate chambers connectable in fluid communication when ready for use, and related method
TWI328448B (en) Medical liquid container and preparation-containing medical liquid container
WO2015092888A1 (en) P.o. medicine administration device
JP2011200261A (en) Dosed article housing container
KR101996841B1 (en) Divided packet, method of manufacturing divided packet, and device for manufacturing divided packet
KR102645146B1 (en) Packaging Pouch for easy opening and easy drinking liquid
JP2007260252A (en) Medical container
JP5873483B2 (en) Medication container
JP2011079543A (en) Small-sized container
WO2016035134A1 (en) Container for swallowing, container set for swallowing, method for manufacturing container set for swallowing, and device for manufacturing container set for swallowing
KR20230060970A (en) Medicine packaging for kids
JP6995121B2 (en) Blister pack
WO2014064840A1 (en) Device for oral drug administration
JP2011206152A (en) Container for concomitant medicine, medicine container, and auxiliary container
JP2016146940A (en) Dosing object package
KR20170022553A (en) Soft capsule containing solid formulation as core ingredient
KR20110004187U (en) Packing sheet to drug
CZ305392B6 (en) Application aid for oral consummation of particularly medicaments
JP2010269132A (en) Medical container

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13899710

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2015553279

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 13899710

Country of ref document: EP

Kind code of ref document: A1